← SynDRA
TRIDOLGOSIR
SynDRA canonical compound SYN0005822 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MAN2A1 |
|---|
| Mechanism of action | alpha mannosidase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- alpha mannosidase inhibitor
- MAN2A1 INHIBITOR
Drug classes
- Adjuvants, Immunologic
- Antineoplastic Agents, Phytogenic
- Enzyme Inhibitors
Cross-references
Synonyms
- Swainsonine
- Swainsonine hydrochloride
- Tridolgosir hydrochloride
- Carbohydrate processing inhibitors, GLYCODesign
- GD-0039
- Transforming growth factor beta inhibitors, GLYCODesign
- GD-0039 analogs, GlycoDESIGN
- swainsonine
- RSY4RK37KQ
- (1S,2R,8R,8aR)-Octahydro-1,2,8-indolizinetriol
- CHEBI:9367
- DTXCID3026356
- tridolgosirum
- RefChem:890073
- (-)-Swainsonine
- Tridolgosir [INN]
- Swainsonine (Synthetic)
- MFCD00017554
- (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol
- 1S-8AB-OCTAHYDRO-INDOLIZIDINE-1A,2A,8B-TRIOL
- NCGC00163481-02
- SWA
- UNII-RSY4RK37KQ
- Swainosine
- Locoweed deriv.
- NSC614553
- 1hww
- Octahydro-1,2,8-indolizinetriol hydrochloride
- A1IGC
- CBiol_001919
- BSPBio_001148
- KBioGR_000488
- KBioSS_000488
- TRIDOLGOSIR [WHO-DD]
- orb419474
- SCHEMBL765848
- KBio2_000488
- KBio2_003056
- KBio2_005624
Look up TRIDOLGOSIR in the interactive SynDRA portal →